1991
DOI: 10.1016/0161-5890(91)90089-3
|View full text |Cite
|
Sign up to set email alerts
|

Antigenic structure of human tumour necrosis factor: Recognition of distinct regions of TNFα by different tumour cell receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

1991
1991
2005
2005

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 24 publications
0
13
0
Order By: Relevance
“…TNF-␣ is the critical stimulating factor in regulating choriodecidual IL-1␤, IL-10, and PGE 2 production, although it should be noted that neutralization of TNF-␣ did not result in a complete inhibition of LPS-stimulated cytokine and PG production. The concentrations of the Abs used were chosen based on the manufacturer's recommendations (34,35) and confirmed by removal of immunodetectable TNF-␣ in preliminary experiments. However, the lack of complete inhibition could reflect inadequate penetration of the neutralizing Abs as they were added concurrently with the LPS treatment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…TNF-␣ is the critical stimulating factor in regulating choriodecidual IL-1␤, IL-10, and PGE 2 production, although it should be noted that neutralization of TNF-␣ did not result in a complete inhibition of LPS-stimulated cytokine and PG production. The concentrations of the Abs used were chosen based on the manufacturer's recommendations (34,35) and confirmed by removal of immunodetectable TNF-␣ in preliminary experiments. However, the lack of complete inhibition could reflect inadequate penetration of the neutralizing Abs as they were added concurrently with the LPS treatment.…”
Section: Discussionmentioning
confidence: 99%
“…The explants were pretreated with the IL-1Ra for 1 h before the addition of LPS and supernatants were harvested 24 h later. The concentrations selected were chosen according to manufacturer's specifications for neutralizing the cytokines (34,35).…”
Section: Immunoneutralization Experimentsmentioning
confidence: 99%
“…TNF-neutralizing mAb (mAb 54) against human TNF was prepared as described previously (29). The following mAbs were purchased: anti-human intercellular adhesion molecule 1 (ICAM-1) (Immunotech, Marseille, France), anti-human endothelial leukocyte adhesion molecule 1 (ELAM-1) (E-selectin) and vascular cell adhesion molecule 1 (VCAM-1) (Becton Dickinson and Co., San Jose, CA), and horseradish peroxidase-conjugated rabbit immunoglobulin (Dakopatts, Copenhagen, Denmark) anti-CD (18).…”
Section: Antibodiesmentioning
confidence: 99%
“…One portion ofthe IgG was used as the capture antibody and another portion of the same IgG was biotinylated as described below and used as the tracer antibody. A panel of murine monoclonal antibodies was prepared against recombinant human TNF-a and their epitope specificities were mapped as described by Rathjen et al (1991). A cocktail of antibodies directed against two non-overlapping domains of the TNF-a molecule were used for the ELISA, one set forcaptureand the other set was biotinylated and used as the tracer.…”
Section: Elisas For Il-l and Tnf-amentioning
confidence: 99%